Effects of thyroid hormone suppression therapy on adverse clinical outcomes in thyroid cancer

NJ McGriff, G Csako, L Gourgiotis, LC Guthrie… - Annals of …, 2002 - Taylor & Francis
BACKGROUND. Long-term thyroid hormone (TH) therapy aiming at the suppression of
serum thyrotropin (TSH) has been traditionally used in the management of well differentiated …

Time perspective and socioeconomic status: A link to socioeconomic disparities in health?

LC Guthrie, SC Butler, MM Ward - Social science & medicine, 2009 - Elsevier
Time perspective is a measure of the degree to which one's thinking is motivated by
considerations of the future, present, or past. Time perspective has been proposed as a potential …

Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia

…, N Bhattacharyya, LC Guthrie… - Human molecular …, 2014 - academic.oup.com
Pathologically elevated serum levels of fibroblast growth factor-23 (FGF23), a bone-derived
hormone that regulates phosphorus homeostasis, result in renal phosphate wasting and …

Clinically important changes in individual and composite measures of rheumatoid arthritis activity: thresholds applicable in clinical trials

MM Ward, LC Guthrie, MI Alba - Annals of the rheumatic diseases, 2015 - ard.bmj.com
Objective Thresholds of minimal clinically important improvement (MCII) are needed to plan
and interpret clinical trials. We estimated MCIIs for the rheumatoid arthritis (RA) activity …

Thyroid Carcinoma in the McCune-Albright Syndrome: Contributory Role of Activating Gsα Mutations

…, SE Crawford, JA Krakoff, LC Guthrie… - The Journal of …, 2003 - academic.oup.com
McCune-Albright syndrome (MAS) is defined by the triad of café-au-lait skin pigmentation,
polyostotic fibrous dysplasia, and hyperfunctioning endocrinopathies, such as precocious …

Clinically important changes in short form 36 health survey scales for use in rheumatoid arthritis clinical trials: the impact of low responsiveness

MM Ward, LC Guthrie, MI Alba - Arthritis care & research, 2014 - Wiley Online Library
Objective Despite wide use of the Short‐Form 36 (SF‐36) health survey in clinical trials of
rheumatoid arthritis (RA), estimates of minimum clinically important improvement (MCII) for its …

Phenotypic and genotypic characterization and treatment of a cohort with familial tumoral calcinosis/hyperostosis‐hyperphosphatemia syndrome

…, S Hatab, E McCarthy, LC Guthrie… - Journal of bone and …, 2016 - academic.oup.com
Familial tumoral calcinosis (FTC)/hyperostosis‐hyperphosphatemia syndrome (HHS) is a
rare disorder caused by mutations in the genes encoding fibroblast growth factor‐23 (FGF23), …

Age‐related changes and effects of bisphosphonates on bone turnover and disease progression in fibrous dysplasia of bone

…, SM Paul, H Kushner, LC Guthrie… - Journal of Bone and …, 2019 - academic.oup.com
Fibrous dysplasia (FD) is a mosaic disease in which bone is replaced with fibro‐osseous
tissue. Lesions expand during childhood, reaching final burden by age 15 years. In vitro data …

Long-term outcomes of letrozole treatment for precocious puberty in girls with McCune–Albright syndrome

…, AM Boyce, BA Brillante, LC Guthrie… - European journal of …, 2016 - academic.oup.com
Objective McCune–Albright syndrome (MAS) is a rare disorder with a broad spectrum
including precocious puberty (PP) due to recurrent estrogen-secreting ovarian cysts. This study …

Treatment of autosomal dominant hypocalcemia type 1 with the calcilytic NPSP795 (SHP635)

…, RI Gafni, B Brillante, LC Guthrie… - Journal of Bone and …, 2019 - academic.oup.com
Autosomal dominant hypocalcemia type 1 (ADH1) is a rare form of hypoparathyroidism
caused by heterozygous, gain‐of‐function mutations of the calcium‐sensing receptor gene (CAR)…